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Abstract 1 
Persons with autism spectrum disorders (ASDs) often display low levels of melatonin, and it 2 
has been suggested that this decrease may be due to low activity of the acetylserotonin O-3 
methyltransferase (ASMT), the last enzyme in the melatonin synthesis pathway. Moreover, 4 
genetic variants in ASMT have been associated with autism, as well as with low ASMT 5 
activity and melatonin levels, suggesting that the low ASMT activity observed in autism may 6 
partly be due to variation within the ASMT gene. In this study, we present a symptom-based 7 
approach to investigate possible associations between ASMT and autistic-like traits (ALTs) in 8 
the general population. To this end, continuous measures of ALTs were assessed in a 9 
nationally representative twin cohort (n=1771) from Sweden and six Single Nucleotide 10 
Polymorphisms (SNP) and a duplication of exon 2 to 8 in ASMT were genotyped. Our results 11 
show a nominally significant association, in girls, between one SNP (rs5949028) in the last 12 
intron of ASMT and social interaction impairments. No significant association, however, was 13 
observed with traits related to language impairment or restricted and repetitive behavior. In 14 
conclusion, our results support the possible involvement of the ASMT gene in ASDs and our 15 
finding that only one of three traits shows association suggests that genetic research may 16 
benefit from taking a symptom-specific approach to identify genes involved in autism 17 
psychopathology.  18 
 19 
Keywords: Autism spectrum disorders, Autistic-like traits, Melatonin, ASMT, Polymorphism 20 
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Introduction 1 
The most prominent characteristics of autism spectrum disorders (ASDs) are impairments in 2 
social interaction and communication, language impairments, and repetitive behaviors [1]. 3 
The notion that ASD represents a spectrum of impairments is, to a large extent, recognized 4 
among both clinicians and researchers (Wing, 1988). Studies of autistic-like traits (ALTs) 5 
have suggested that an ASD diagnosis represents the extreme lower end of normally 6 
distributed abilities for social communication (Constantino et al., 2004, Posserud et al., 2006).  7 
Moreover, ALTs and ASDs have been shown to share common genetic influences 8 
(Lundstrom et al., 2012, Robinson et al., 2011). A theoretical partition into three dimensions 9 
of autism, i.e. restricted and repetitive behavior, impairments in social communication and 10 
language impairments, has been confirmed in several studies (for review see (Happe and 11 
Ronald, 2008)), and these dimensions have been shown to be influenced by separate genetic 12 
factors when investigated in the general population (Ronald et al., 2011). Moreover it has 13 
been demonstrated that girls and boys display different ALTs, both among children with ASD 14 
(Mandy et al., 2012) and among those children that do not meet diagnostic criteria for ASD 15 
(Dworzynski et al., 2012).  16 
Melatonin is involved in circadian rhythm regulation, including the sleep/wake cycle, but it 17 
also has an array of other functions, such as regulation of immune responses and 18 
neurodevelopmental processes (Stehle et al., 2011). It is released mainly by the pineal gland 19 
during the night and is produced by the conversion of serotonin to N-acetylserotonin by the 20 
enzyme arylalkylamine N-acetyltransferase (AA-NAT) followed by the conversion of N-21 
acetylserotonin to melatonin by acetylserotonin methyltransferase (ASMT). AA-NAT is 22 
generally considered to be the rate-limiting enzyme but recent studies have suggested that 23 
variable expression of ASMT has an important effect on the regulation of melatonin synthesis 24 
in humans (Maronde et al., 2011), and that the rate-limiting role partly is taken over by 25 
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ASMT during night (Liu and Borjigin, 2005). Melatonin is often used to treat sleep 1 
impairments in persons with ASD (Rossignol and Frye, 2011, Malow et al., 2011) and low 2 
melatonin levels in ASD have been reported by numerous studies (Ritvo et al., 1993, Nir et 3 
al., 1995, Miyamoto et al., 1999, Yamashita et al., 1999, Kulman et al., 2000, Tordjman et 4 
al., 2005, Melke et al., 2008, Mulder et al., 2010, Tordjman et al., 2012). In connection to the 5 
major hypotheses put forth for autism etiology, i.e., neural growth (Torres-Farfan et al., 2009) 6 
and synapse formation (Ishida et al., 2005), melatonin has been demonstrated to modulate 7 
neurite outgrowth in cultured neuronal cells (Lavebratt et al., 2010). Taken together, previous 8 
findings hence suggest that an impaired melatonin synthesis and/or secretion may be 9 
associated with ASDs and related phenotypes. Indeed, it has been demonstrated that the 10 
melatonin deficit in persons with autism correlates with low activity of the ASMT enzyme, 11 
and, in some patients, are associated with mutations in the ASMT gene (Melke et al., 2008). In 12 
addition, rare functional mutations in ASMT have been identified in persons with ASD (Wang 13 
et al., 2013, Jonsson et al., 2010, Toma et al., 2007). Moreover, it has been demonstrated that 14 
polymorphisms in the promoter region of ASMT influences mRNA transcription and are 15 
associated with ASDs (Melke et al., 2008). However, negative results from association 16 
studies of ASMT polymorphisms have also been published (Toma et al., 2007, Holt et al., 17 
2010, Wang et al., 2013) and none of the Single Nucleotide Polymorphisms (SNP) in ASMT 18 
reached genome-wide statistical significance for association in the study by Anney et al. 19 
(Anney et al., 2010); the only large, genome wide, association study (GWA) on ASD that has 20 
included the ASMT gene. In addition to the results from mutation screening and association 21 
studies, a microduplication (~18 kb) has been identified in the ASMT gene and found to be 22 
significantly more common in ASDs (5.8%) than in controls (1.6%) (Cai et al., 2008).  23 
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Based on previous suggestions of ASMT as a candidate gene for autism susceptibility, we 1 
have investigated the possible association between polymorphisms in the ASMT gene and 2 
autistic-like traits in children from the general population.   3 
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Materials and methods 1 
Subjects 2 
The Child and Adolescent Twin Study in Sweden (CATSS) is a nationwide cohort that 3 
focuses on all Swedish twins turning 9 or 12 years since 2004 (Anckarsater et al., 2011). The 4 
CATSS study has an 80% response rate, making it a highly representative population sample 5 
(Anckarsater et al., 2011). Data is currently available on 12,446 children: n=5944 for 9-year-6 
olds and 6496 for 12-year-olds. The present study used genetic material from the first DNA 7 
collection from CATSS (both 9- and 12-year-olds) including information from 1771 subjects 8 
in total (887 girls and 884 boys). Notably, since the sample is recruited from the general 9 
population, it includes the full variation of ALTs, i.e., also subjects meeting the criteria for 10 
clinical diagnoses of ASD and other neuropsychiatric disorders. Moreover, the focus of our 11 
study was to investigate the possible influence of common genetic variation in ASMT on 12 
ALTs. Hence, 24 subjects were excluded from the analyses due to documented brain damage 13 
(most commonly cerebral palsy) or a known genetic syndrome (most commonly Down’s 14 
syndrome but also fragile X syndrome) since individuals with these conditions are well 15 
known to display a high degree of autism-related symptoms (Zafeiriou et al., 2007). The total 16 
number of subjects included in the statistical analyses is hence 1747 and consist of 357 17 
monozygotic twin (MZ) pairs, 500 dizygotic (DZ) twin pairs and 33 subjects without their co-18 
twin. To determine twin zygosity a panel of 47 SNPs were used (Hannelius et al., 2007). 19 
Notably, although all statistical analyses (see below) were adjusted for kinship, the population 20 
is analyzed as a representative sample of children from the general population in Sweden. The 21 
CATSS study has ethical approval from the Karolinska Institute Ethical Review Board, and 22 
informed consent was obtained from the participants. 23 
Measurements  24 
Parents of all twins were contacted when their twins turned 9 or 12 years and asked to 25 
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participate in a telephone interview containing, among other instruments, the Autism–Tics, 1 
Attention-Deficit/Hyperactivity Disorder (AD/HD), and Other Co-morbidities inventory (A-2 
TAC) (Hansson et al., 2005, Larson et al., 2010). The A-TAC is a sensitive tool for screening 3 
the general population for child autism spectrum disorders and associated conditions and can 4 
also be used as a dimensional measure (Larson et al., 2010).  ALTs were measured by 17 5 
items in the A-TAC, including 12 questions specifically addressing the DSM-IV symptom 6 
criteria for autistic disorder. Each of the 17 items has three response categories; ”no” (coded 7 
0), “yes, to some extent” (coded 0.5), and “yes” (coded 1.0). The measure of total ASD scores 8 
is the sum of the 17 A-TAC items related to autism/ASD. Out of these items, six correspond 9 
to the language impairment, six to the social interaction impairment and five to the restricted 10 
and repetitive behavior module. The A-TAC is freely available from the Internet as an 11 
appendix to the published article by Larson et al. (2010). The A-TAC has previously been 12 
used as a dimensional measure of autistic-like traits in genetic association studies (Walum et 13 
al., 2012, Molero et al., 2013) and in several studies to investigate the heritability of 14 
(Lundstrom et al., 2012), and relation between, different neurodevelopmental and behavioral 15 
problems in children from the general population (Anckarsater et al., 2008, Lundstrom et al., 16 
2011, Lichtenstein et al., 2010).  In addition, the A-TAC questionnaire have been shown to be 17 
a valid instrument to screen for and to identify cases of ASD and overlapping 18 
neuropsychiatric/developmental disorders (Larson et al., 2010). 19 
Polymorphism selection and genotyping 20 
DNA was extracted from saliva samples using OraGene® DNA self-collection kit (DNA 21 
Genotek, Inc., Ottawa, Ontario, Canada). Six SNPs in the ASMT gene (table 1) were 22 
genotyped with the Kompetitive Allele Specific PCR (KASP™) genotyping system (LGC, 23 
Kbiosciences, Herts, UK). To select SNPs for association analyses, genotyping data for the 24 
ASMT gene (including 1kb up- and downstream of the coding region) was downloaded from 25 
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the International Haplotype Mapping Project web site (http://www.hapmap.org) for the 1 
Caucasian population with European ancestry from the Centre d'etude du polymorphisme 2 
humain (CEPH) collection. The data was then incorporated into the Haploview program and 3 
the Tagger function within Haploview was used to assign Tag SNPs (Gustafsson et al., 2011). 4 
Six SNPs in the ASMT gene (rs1128551, rs6644777, rs4446909, rs5989681, rs6588809, and 5 
rs5949028) were chosen, by pairwise tagging, to capture the common variations within these 6 
genes and the surrounding area with a minimum r
2
 of 0.80 (for their location and the SNPs 7 
which they tag). SNPs rs4446909 and rs5989681 were force-included based on previous 8 
findings (Melke et al., 2008) and  the missense SNP rs6588809 in exon 7 of the gene was 9 
force-included based on its possible function role. SNPs with a minor allele frequency (MAF) 10 
>0.2 in the Caucasian sample were chosen to ensure adequate power given our sample size, 11 
which was fixed by external limitations prior to the study. Linkage disequilibrium (LD) in our 12 
population, measured by D’ values, between the six SNPs are presented in table 2. All SNPs 13 
were found to be in Hardy Weinberg Equilibrium (p > 0.01), which was calculated by using 14 
one subject in each MZ twin pair and both subjects from the DZ twin pairs. The genotyping 15 
success rate was over 94% (table 1).  16 
Analysis of the copy number variation in the ASMT gene was performed using quantitative 17 
polymerase chain reaction (q-PCR). One probe in exon six was chosen based on previous 18 
findings showing a duplication in this region in the ASMT gene (Cai et al., 2008). The q-PCR-19 
probe was designed using GeneAssist™ Copy Number Assay Workflow Builder (Applied 20 
Biosystems) and the reference assay used was the TaqMan
®
 Copy Number Reference Assay 21 
RNase P. The assay was run in duplicates and three calibrator samples were used. qPCR 22 
analysis was performed using 7900HT Sequence detection system Software v2.4 (Applied 23 
Biosystems) and CopyCaller
®
 (Applied Biosystems) was used to analyze the copy number 24 
variation results. The genotyping of the duplication had a success rate of over 93% (table 1).  25 
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 1 
Statistical analysis 2 
Statistical association between six SNPs and the duplication in the ASMT gene and continuous 3 
measures of ALTs, including the A-TAC modules restricted and repetitive behavior, language 4 
impairment and social interaction impairment, were estimated using linear mixed effect 5 
models in the MIXED procedure (PROC MIXED) of SAS 9.3 (SAS Institute, Inc., Cary, NC). 6 
This model allowed us to adjust for the dependent nature of the twin observations i.e., A-TAC 7 
scores from all genotyped subjects were included in the analyses. Specifically, given that MZ 8 
twins, on average, share 100% of their genome while DZ twins only share 50% of their 9 
genome, and that MZ twins are more similar than DZ twins in ALT scores (Lundstrom et al., 10 
2012), we specified two separate variance-covariance matrices for MZ twins and for DZ twins. 11 
The sample size also made it possible to analyze girls and boys separately. Significant p-12 
values were corrected for analyses of six SNPs and three A-TAC domains, using Bonferroni 13 
correction for multiple testing. Association analysis of the duplication in the ASMT gene was 14 
only performed with regards to the total ALT, i.e., not with each module of ALTs nor sex-15 
specific analysis, due to the low frequency of the duplication. 16 
The G*Power software was used to asses effect-size calculations and post-hoc power analysis 17 
for the association analyses of the six SNPs and the duplication in the ASMT gene. These 18 
analyses are based on a significant p-value (0.05/18=0.0028) corrected for six SNPs and three 19 
A-TAC modules for the total population, i.e., not corrected for kinship, and for the sex 20 
specific analyses.  21 
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Results 1 
Association analyses of the six ASMT SNPs and A-TAC scores revealed a significant 2 
association, in girls, between an intronic SNP (rs5949028, MAF=0.4) and social interaction 3 
impairment (p=0.0023, η2= 0.015), where the C-allele carriers were shown to have higher 4 
scores (table 3). Although we did not see significant association between rs5949028 and the 5 
two other modules, we could see a trend showing that female C-allele carriers also had higher 6 
scores on restricted and repetitive behavior (p=0.052). We did not see any significant 7 
associations between the other SNPs and A-TAC scores, however, we could see a trend that 8 
girls carrying the G-allele of one of the promoter SNPs (rs4446909) had higher scores on 9 
language impairment (p=0.074). No significant associations for any of the studied SNPs were 10 
observed in boys. In our study, we had a power of 80% to detect small effect-sizes (η2=0.01) 11 
and a power of 100% to detect medium to large effect sizes (η2>0.06) for analyses in the total 12 
population. For the sex-specific analyses we had a power of 36% to detect small effect-sizes 13 
and a power of 100% to detect medium to large effect sizes. Effect sizes were determined 14 
according to Cohen´s conventional criteria (Zafeiriou et al., 2007).  15 
In our study, we also investigated a microduplication of exon 2 to 8 in the ASMT gene, which 16 
was found in 27 individuals (1.7%) in our population. All these individuals were shown to 17 
have one extra copy of the region investigated, except for one monozygotic twin pair who had 18 
two extra copies. This duplication was analyzed with respect to total ASD scores, although no 19 
significant associations could be shown (p=0.662). For this analysis, we had a power of 98% 20 
in our total sample to detect small effect sizes (η2>0.01). 21 
Discussion 22 
Biochemical studies have provided evidence for the importance of melatonin in autism related 23 
phenotypes. In addition, both mutation screenings (Toma et al., 2007, Melke et al., 2008) and 24 
association studies (Melke et al., 2008) have implicated the ASMT gene in ASD. The results 25 
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from the present study tentatively suggest an association between an intronic ASMT 1 
polymorphism (rs5949028) and ALTs in children from the general population. Our results do 2 
not suggest a major involvement of this polymorphism in ASD since the association was only 3 
observed in girls and the effect size of the studied SNP on social interaction impairment 4 
scores was small (η2= 0.015). Previously, the rs5949028 has been investigated in one case-5 
control study of ASD (Holt et al., 2010), with negative results and this polymorphism has not 6 
been genotyped in any of the large GWAs targeting common variants affecting risk for ASDs 7 
(Anney et al., 2010, Wang et al., 2009, Weiss et al., 2009). Notably, of the large GWAs on 8 
ASDs, only Anney and coworkers (Anney et al., 2010) uses a genotyping array (Illumina’s 9 
1M Beadchip) that includes any SNPs in the ASMT gene at all. In their study, none of the five 10 
ASMT polymorphisms analyzed reached genome-wide significance for association with ASDs 11 
(Anney et al., 2010). However, neither the SNPs investigated in our study, nor the SNPs that 12 
have been significantly associated with ASD in previous studies (Melke et al., 2008), were 13 
genotyped (Anney et al., 2010). To the best of our knowledge, only one genome wide study 14 
investigating dimensional measures of autistic-like traits has been published (Ronald et al., 15 
2010), however, the genotyping array (Affymetrix 500K) used in this study does not genotype 16 
any SNPs in ASMT. 17 
None of the promoter SNPs (rs4446909 and rs5989681) previously associated with ASD were 18 
found to influence ALTs in our study. However, in line with previous findings, we could see 19 
that carriers of the G-allele of rs4446909 had slightly higher scores for language impairments 20 
in girls (p=0.074).  21 
The result that different SNPs in ASMT have been associated in different studies may be due 22 
to limited gene coverage or variation in LD-patterns between samples. It is, however, also 23 
possible that the promoter SNPs indeed are associated with more severe phenotypic 24 
expressions of autism, i.e., ASD diagnosis, whereas the SNP (rs5949028) in our study is more 25 
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associated with social behavior in the general population. 1 
Recently, further support for an involvement of the ASMT gene in ASD was presented in a 2 
Multiplex Ligation-dependent Probe Amplification (MLPA) study showing that a duplication 3 
in the ASMT gene was significantly more common in ASDs, as compared to controls (Cai et 4 
al., 2008), suggesting that the expression of the ASMT protein may be altered in persons with 5 
ASD. In our study, however, we could not observe any significant association between this 6 
duplication and measures of ALTs. 7 
The A-TAC questionnaire and the relatively large sample size permitted us to investigate the 8 
different dimensions of ALTs separately, revealing association between the ASMT gene and 9 
traits related to impairments in social interaction but neither with restricted/repetitive behavior 10 
nor symptoms related to language impairments. Our findings are hence in line with the notion 11 
that the different ALTs are influenced by separate sets of genes (Ronald et al., 2011).  12 
The large proportion of female subjects in our study also allowed us to analyze boys and girls 13 
separately, which is often not possible in case-control studies with low prevalence of girls 14 
with ASDs.  The significant association for girls in our study is in line with the suggestion 15 
that different mechanisms are involved in ASDs for males and females (Lai et al., 2011). In 16 
addition, it has also been suggested that the ASD phenotype differ between boys and girls, 17 
and attempts have been made to modify current diagnostic manuals for a sex specific 18 
diagnostic criteria (Kopp and Gillberg, 2011).   19 
There are limitations of our study. Most importantly, our sample size is moderate and the 20 
small effect size of the ASMT polymorphism on ALTs observed in this study obviously does 21 
not mean that this polymorphism may serve as a predictor for autism psychopathology. 22 
Hence, our results should be interpreted with caution and either previous findings, or our 23 
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results, may be coincidental findings. In addition, the associated polymorphism has, to our 1 
knowledge, not been investigated functionally, and the intronic position does not implicate a 2 
functional effect on the ASMT protein. Our finding may thus reflect an indirect association, 3 
i.e., the associated polymorphism could be partly in linkage disequilibrium with a more rare 4 
functional variant. However, by demonstrating a modest but significant influence of a SNP in 5 
the ASMT gene on an autism related phenotype, our results support the possible involvement 6 
of ASMT as a risk factor for autism susceptibility. Our results also show that not all traits of 7 
autism are associated with the investigated gene, suggesting that genetic research may benefit 8 
from taking a symptom-specific approach to finding genes associated with autism related 9 
phenotypes. In addition, the association appears in girls only, further emphasizing the 10 
importance of sex-specific analyses in studies of ASDs. Finally, in our study, no association 11 
between the duplication of ASMT and autism was found. However, the low frequency of this 12 
duplication requires association studies in larger samples and to elucidate its role in autism 13 
psychopathology, functional studies are highly warranted. 14 
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Tables 1 
Table 1. Polymorphisms genotyped in ASMT. 2 
Polymorphism Location MAF Alleles 
Genotyping 
success rate 
rs1128551 5’ 0.45 C/T 0.94 
rs6644777 5’ 0.28 A/G 0.95 
rs4446909 5’ 0.20 A/G 0.94 
rs5989681 5’ 0.24 C/G 0.99 
rs6588809 Exon 7 0.41 C/T 0.98 
rs5949028 intron 9 0.39 T/C 0.94 
Duplication Exon 2-8 0.01 DUP/no DUP 0.93 
 3 
  4 
19 
 
Table 2. Linkage disequilibrium (LD), measured by D’ values, between the six SNPs in ASMT. 1 
 
rs1128551 rs6644777 rs4446909 rs5989681 rs5949028 rs6588809 
rs1128551 - 0.007 0.009 0.001 0.092 0.017 
rs6644777 0.007 - 0.502 0.531 0.202 0.016 
rs4446909 0.009 0.502 - 0.979 0.005 0.036 
rs5989681 0.001 0.531 0.979 - 0.057 0.004 
rs5949028 0.092 0.202 0.005 0.057 - 0.262 
rs6588809 0.017 0.016 0.036 0.004 0.262 - 
20 
 
Table 3. Autistic-like traits, as assessed with the A-TAC, by ASMT genotypes.  
  
 
Restricted & repetitive behavior  
 
Language impairment  
 
Social interaction impairment 
  
Mean A-TAC score (SD) 
 
Mean A-TAC score (SD) 
 
Mean A-TAC score (SD) 
  
All Boys Girls 
 
All Boys Girls 
 
All Boys Girls 
rs1128551 
           
 
C/C (356) 0.26 (0.73) 0.39 (0.93) 0.15 (0.45) 
 
0.32 (0.73) 0.44 (0.89) 0.22 (0.51) 
 
0.35 (0.80) 0.47 (1.02) 0.24 (0.52) 
 
C/T (783) 0.28 (0.64) 0.36 (0.73) 0.19 (0.52) 
 
0.29 (0.62) 0.40 (0.73) 0.18 (0.46) 
 
0.30 (0.64) 0.37 (0.71) 0.22 (0.54) 
 
T/T (505) 0.33 (0.76) 0.43 (0.86) 0.22 (0.62) 
 
0.37 (0.77) 0.48 (0.92) 0.26 (0.55) 
 
0.38 (0.84) 0.47 (1.00) 0.27 (0.60) 
 
P-value 0.460 0.644 0.436 
 
0.427 0.905 0.138 
 
0.329 0.385 0.468 
rs6644777 
           
 
A/A (124) 0.29 (0.6) 0.40 (0.72) 0.17 (0.39) 
 
0.39 (0.69) 0.54 (0.81) 0.22 (0.47) 
 
0.33 (0.64) 0.43 (0.71) 0.23 (0.53) 
 
A/G (687) 0.30 (0.73) 0.41 (0.82) 0.20 (0.60) 
 
0.32 (0.72) 0.43 (0.86) 0.21 (0.53) 
 
0.35 (0.78) 0.43 (0.91) 0.27 (0.61) 
 
G/G (854) 0.29 (0.71) 0.38 (0.83) 0.20 (0.53) 
 
0.32 (0.69) 0.41 (0.80) 0.22 (0.52) 
 
0.32 (0.74) 0.41 (0.87) 0.23 (0.56) 
 
P-value 0.950 0.970 0.934 
 
0.623 0.552 0.936 
 
0.570 0.898 0.814 
rs4446909 
           
 
A/A (72) 0.15 (0.37) 0.32 (0.56) 0.05 (0.16) 
 
0.20 (0.51) 0.50 (0.76) 0.04 (0.14) 
 
0.19 (0.39) 0.38 (0.55) 0.10 (0.22) 
 
A/G (517) 0.31 (0.75) 0.41 (0.89) 0.20 (0.56) 
 
0.31 (0.70) 0.42 (0.87) 0.21 (0.44) 
 
0.34 (0.76) 0.40 (0.91) 0.28 (0.59) 
 
G/G (1052) 0.29 (0.69) 0.37 (0.78) 0.20 (0.57) 
 
0.34 (0.71) 0.43 (0.80) 0.24 (0.57) 
 
0.34 (0.74) 0.42 (0.85) 0.24 (0.58) 
 
P-value 0.315 0.723 0.338 
 
0.454 0.853 0.074 
 
0.373 0.995 0.207 
rs5989681 
           
 
G/G (1004) 0.29 (0.68) 0.37 (0.78) 0.20 (0.55) 
 
0.33 (0.70) 0.41 (0.79) 0.24 (0.58) 
 
0.32 (0.72) 0.41 (0.85) 0.24 (0.56) 
 
G/C (618) 0.31 (0.75) 0.41 (0.87) 0.20 (0.59) 
 
0.33 (0.70) 0.44 (0.86) 0.21 (0.45) 
 
0.36 (0.8) 0.44 (0.93) 0.29 (0.63) 
 
C/C (103) 0.22 (0.48) 0.45 (0.65) 0.06 (0.16) 
 
0.30 (0.62) 0.52 (0.82) 0.14 (0.35) 
 
0.25 (0.61) 0.47 (0.86) 0.10 (0.22) 
 
P-value 0.690 0.732 0.240 
 
0.834 0.735 0.440 
 
0.358 0.751 0.137 
21 
 
rs6588809 
           
 
C/C (284) 0.27 (0.67) 0.39 (0.82) 0.14 (0.41) 
 
0.33 (0.67) 0.48 (0.84) 0.16 (0.33) 
 
0.34 (0.75) 0.46 (0.93) 0.21 (0.45) 
 
T/C (848) 0.27 (0.68) 0.33 (0.76) 0.21 (0.59) 
 
0.29 (0.65) 0.37 (0.73) 0.22 (0.57) 
 
0.29 (0.69) 0.35 (0.79) 0.23 (0.58) 
 
T/T (582) 0.34 (0.75) 0.48 (0.88) 0.18 (0.54) 
 
0.37 (0.77) 0.5 (0.93) 0.23 (0.53) 
 
0.39 (0.81) 0.5 (0.94) 0.29 (0.62) 
 
P-value 0.263 0.127 0.375 
 
0.226 0.239 0.276 
 
0.051 0.153 0.295 
rs5949028 
           
 
C/C (578) 0.33 (0.81) 0.41 (0.91) 0.26 (0.69) 
 
0.37 (0.78) 0.49 (0.93) 0.25 (0.56) 
 
0.36 (0.77) 0.39 (0.86) 0.33 (0.66) 
 
T/C (843) 0.28 (0.64) 0.36 (0.75) 0.18 (0.47) 
 
0.31 (0.67) 0.40 (0.79) 0.21 (0.51) 
 
0.33 (0.75) 0.43 (0.90) 0.22 (0.53) 
 
T/T (219) 0.23 (0.57) 0.40 (0.75) 0.06 (0.19) 
 
0.25 (0.51) 0.37 (0.64) 0.14 (0.30) 
 
0.27 (0.62) 0.43 (0.81) 0.12 (0.26) 
 
P-value 0.269 0.649 0.052 
 
0.097 0.128 0.137 
 
0.383 0.930 
0.0023 
(Pc=0.041*) 
Association analysis for all subjects, boys and girls between genotypes and the different modules of autism spectrum disorders, as assessed by the A-TAC  
*Pc=p-value corrected for multiple analyses using the Bonferroni method.  
 
